EWA
IRON icon

EverSource Wealth Advisors’s Disc Medicine IRON Stock Holding History

EverSource Wealth Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24K Sell
17
-54
-76% -$3.71K ﹤0.01% 3893
2026
Q1 		$4.54K Buy
71
+4
+6% +$278 ﹤0.01% 3311
2025
Q4 		$5.32K Sell
67
-8
-11% -$676 ﹤0.01% 3101
2025
Q3 		$4.96K Buy
75
+3
+4% +$178 ﹤0.01% 3153
2025
Q2 		$3.81K Buy
72
+62
+620% +$2.91K ﹤0.01% 3267
2025
Q1 		$496 Buy
+10
New +$556 ﹤0.01% 3462

Other funds holding IRON

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

EverSource Wealth Advisors's IRON Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Disc Medicine (IRON) stake by 76% in Q2 2026, selling an estimated $3.71K and leaving 17 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

EverSource Wealth Advisors first reported a position in IRON in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.32K in Q4 2025. 38 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • EverSource Wealth Advisors held 17 shares of Disc Medicine worth $1.24K as of Q2 2026.
  • EverSource Wealth Advisors sold 54 Disc Medicine shares in Q2 2026, an estimated $3.71K.
  • Disc Medicine made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3893 holding.
  • EverSource Wealth Advisors first reported a position in Disc Medicine in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Disc Medicine position peaked at $5.32K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.